What happened
Artificial Intelligence-Driven Nanomedicine: From Drug Formulation and Nanocarrier Design to Clinical Translation
SourceMultidisciplinary Digital Publishing InstitutepublicationBiotech
Artificial Intelligence-Driven Nanomedicine: From Drug Formulation and Nanocarrier Design to Clinical Translation
Publication signal: Artificial Intelligence-Driven Nanomedicine: From Drug Formulation and Nanocarrier Design to Clinical Translation
Factual summary
Why it matters
Recent source-backed research output for AISci Stage A browsing.
SourceMultidisciplinary Digital Publishing InstituteLimitations
AISci rank score does not assess scientific quality or citation impact.
SourceMultidisciplinary Digital Publishing InstituteLinked output
Artificial Intelligence-Driven Nanomedicine: From Drug Formulation and Nanocarrier Design to Clinical TranslationpaperPeople
No reviewed person relationship is attached to this event.
Organizations
No reviewed organization relationship is attached to this event.
Topics
Problems
No reviewed problem relationship is attached to this event.
Relationship evidence
Clinical and Regulatory
Controlled AISci Stage A topic for Clinical and Regulatory.
Artificial Intelligence-Driven Nanomedicine: From Drug Formulation and Nanocarrier Design to Clinical Translation
Artificial Intelligence-Driven Nanomedicine: From Drug Formulation and Nanocarrier Design to Clinical Translation
Timeline
- publicationArtificial Intelligence-Driven Nanomedicine: From Drug Formulation and Nanocarrier Design to Clinical Translation